Home/Filings/4/0001179110-22-000966
4//SEC Filing

Weber David M 4

Accession 0001179110-22-000966

CIK 0000815094other

Filed

Feb 8, 7:00 PM ET

Accepted

Feb 9, 5:43 PM ET

Size

32.0 KB

Accession

0001179110-22-000966

Insider Transaction Report

Form 4
Period: 2022-02-07
Weber David M
Chief Operating Officer
Transactions
  • Exercise/Conversion

    Common Stock, $.01 par value

    2022-02-08$21.55/sh+7,413$159,750138,727 total
  • Exercise/Conversion

    Common Stock, $.01 par value

    2022-02-09$21.55/sh+3,112$67,064134,426 total
  • Exercise/Conversion

    Common Stock, $.01 par value

    2022-02-07$21.55/sh+300$6,465131,614 total
  • Sale

    Common Stock, $.01 par value

    2022-02-07$300.25/sh300$90,076131,314 total
  • Sale

    Common Stock, $.01 par value

    2022-02-08$300.40/sh4,884$1,467,140133,843 total
  • Sale

    Common Stock, $.01 par value

    2022-02-08$301.10/sh641$193,003133,202 total
  • Sale

    Common Stock, $.01 par value

    2022-02-08$310.00/sh1,888$585,280131,314 total
  • Sale

    Common Stock, $.01 par value

    2022-02-09$310.19/sh3,112$965,311131,314 total
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2022-02-0710,8250 total
    Exercise: $21.55From: 2015-05-14Exp: 2024-05-14Common Stock (0 underlying)
Holdings
  • Common Stock, $.01 par value

    (indirect: By Trust)
    15,497
  • Stock Option (right to buy)

    Exercise: $134.51From: 2018-05-15Exp: 2027-05-15Common Stock (0 underlying)
    8,000
  • Stock Option (right to buy)

    Exercise: $381.97From: 2019-05-16Exp: 2028-05-16Common Stock (0 underlying)
    6,500
  • Stock Option (right to buy)

    Exercise: $66.25From: 2016-05-13Exp: 2025-05-13Common Stock (0 underlying)
    10,000
  • Stock Option (Right to Buy)

    Exercise: $223.90From: 2021-05-29Exp: 2030-05-29Common Stock (0 underlying)
    5,000
  • Stock Option (right to buy)

    Exercise: $99.62From: 2017-05-24Exp: 2026-05-24Common Stock (0 underlying)
    7,000
  • Stock Option (Right to Buy)

    Exercise: $266.39From: 2020-05-30Exp: 2029-05-30Common Stock (0 underlying)
    6,000
  • Stock Option (Right to Buy)

    Exercise: $283.88From: 2022-05-25Exp: 2031-05-25Common Stock (0 underlying)
    4,969
Footnotes (10)
  • [F1]Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
  • [F10]This price represents the sale price of the transactions on the reported date at $310.19. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
  • [F2]These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.
  • [F3]Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2015 Omnibus Incentive Plan.
  • [F4]Exercise of stock options pursuant to reporting owners 10b5-1 plan.
  • [F5]Sale of common stock pursuant to reporting owner's 10b5-1 plan.
  • [F6]This price represents the sale price of the transactions on the reported date at $300.2533. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
  • [F7]This price represents the sale price of the transactions on the reported date at $300.3973. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
  • [F8]This price represents the sale price of the transactions on the reported date at $301.0966. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
  • [F9]This price represents the sale price of the transactions on the reported date at $310.00. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.

Issuer

ABIOMED INC

CIK 0000815094

Entity typeother

Related Parties

1
  • filerCIK 0001399519

Filing Metadata

Form type
4
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 5:43 PM ET
Size
32.0 KB